Zobrazeno 1 - 10
of 207
pro vyhledávání: '"C T, van Buren"'
Publikováno v:
Transplantation Proceedings. 41:4407-4410
Light-Chain Deposition Disease (LCDD) frequently recurs after renal transplantation, displaying a pernicious course. Herein we have described a 39-year-old Caucasian man with a history of immunoglobulin G-kappa multiple myeloma who failed two chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb15eba063125d2f27558c114adb3669
https://doi.org/10.1016/j.transproceed.2009.10.005
https://doi.org/10.1016/j.transproceed.2009.10.005
Autor:
Stephen M. Katz, C. T. Van Buren, Eva McKissick, A. Lawless, H Podder, Ronald H. Kerman, Richard J. Knight, Barry D. Kahan
Publikováno v:
Clinical Transplantation. 22:645-650
Of 25 simultaneous pancreas-kidney transplant (SPK) recipients treated with thymoglobulin induction, sirolimus and reduced-dose cyclosporine (CsA), 18 low-immune responders (non-African-Americans, PRA < 30%) were withdrawn from prednisone on post-tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08c4bfa1ded7ce3953de0892bca57948
https://doi.org/10.1111/j.1399-0012.2008.00839.x
https://doi.org/10.1111/j.1399-0012.2008.00839.x
Publikováno v:
Clinical Nephrology. 66:67-70
We report the extremely rare recurrence of intimal fibroplasia, a rare form of fibromuscular dysplasia, in a kidney recipient at 6 months after transplantation from a living-related donor. The patient was successfully treated and maintains good kidne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3652f22bb93980de39861510192a358
https://doi.org/10.5414/cnp66067
https://doi.org/10.5414/cnp66067
Autor:
C. Barcenas, Carlos Benavides, Barry D. Kahan, Richard J. Knight, C. T. Van Buren, K. H. Mahmoud
Publikováno v:
Transplantation Proceedings. 37:822-826
Aims. Randomized controlled studies suggest an increased incidence of perioperative wound complications among sirolimus-treated renal transplant patients. The present study analyzed the effect of rabbit antithymocyte globulin (rATG) on these postoper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de61bb8ee25a508f8d5d548b9f37d102
https://doi.org/10.1016/j.transproceed.2004.12.121
https://doi.org/10.1016/j.transproceed.2004.12.121
Autor:
C. T. Van Buren, Barry D. Kahan, Ronald H. Kerman, K. Mahalati, L. Schoenberg, Stephen M. Katz, Yarkın Kamil Yakupoğlu, F. T. Aki, Richard J. Knight, J. Pobielski
Publikováno v:
ResearcherID
ON APRIL 13, 1993, a phase I trial was initiated to assess the safety and pharmacokinetic behavior of ascending doses of a new immunosuppressant discovered by Sehgal and applied in animal transplant models by Calne et al and Morris et al. Forty stabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::040a7b1f1730196bfd740e03e8070d26
https://doi.org/10.1016/s0041-1345(03)00351-8
https://doi.org/10.1016/s0041-1345(03)00351-8
Autor:
PA Kelly, S H Katz, Diana L. Urbauer, Jeanette M. Podbielski, Barry D. Kahan, Kimberly L. Napoli, C. T. Van Buren, I Hussein
Publikováno v:
Clinical Transplantation. 14:97-109
UNLABELLED We sought to examine the potential benefits of therapeutic drug monitoring of sirolimus, a potent immunosuppressive agent that displays a pleiotropic array of side effects. METHODS A high-performance liquid chromatography (LC) procedure co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19c1e8d0684775c197274cf48c5a40c6
https://doi.org/10.1034/j.1399-0012.2000.140201.x
https://doi.org/10.1034/j.1399-0012.2000.140201.x
Autor:
Stephen M. Katz, P Pryzbylowski, I Buyse, J. Ruth, S Warnell, Kahan Bd, Scott A. Gruber, Ronald H. Kerman, C. T. Van Buren, B. Susskind
Publikováno v:
Transplantation. 68:1855-1858
Background. At our transplant center, primary recipients of either a haplo-identical (haplo-ID) living related (LRD) or a cadaveric (CAD) donor renal allograft are transplanted after a negative donor-specific IgG anti-human globulin (AHG) cross-match
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af2def0374030948320970d1a4939628
https://doi.org/10.1097/00007890-199912270-00007
https://doi.org/10.1097/00007890-199912270-00007
Autor:
J Von Fellenberg, S Appel-Dingemanse, R. Wong, S H Katz, Barry D. Kahan, C Carter, C. T. Van Buren
Publikováno v:
Transplantation. 68:1100-1106
Background and Methods. This phase I, randomized, blinded, placebo-controlled study assessed the safety profile and pharmacokinetics of a 4-week course of once-daily, sequential ascending doses (0.75, 2.5, or 7.5 mg/day) of SDZ-RAD (RAD) capsules in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee03b1cb5aae43d0c52ecd0989e93442
https://doi.org/10.1097/00007890-199910270-00007
https://doi.org/10.1097/00007890-199910270-00007
Autor:
B. Radovancevic, O.H. Frazier, B. Susskind, P Przybylowski, M Balogna, C. T. Van Buren, Stephen M. Katz, Ronald H. Kerman, Kahan Bd
Publikováno v:
Transplantation. 67:258-262
Background. At our transplant center, cardiac allograft recipients undergo transplantation following a negative IgG anti-human globulin (AHG) crossmatch (XM). Flow cytometry crossmatching (FCXM) is a more sensitive XM procedure than the AHG XM proced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64149972fba8e63c395a3269bb5c2f49
https://doi.org/10.1097/00007890-199901270-00012
https://doi.org/10.1097/00007890-199901270-00012